Research and Markets (http://www.researchandmarkets.com/research/r42rmg/global_rheumatoid) has announced the addition of the "Global Rheumatoid Arthritis Epidemiology and Patient Flow Analysis - 2015" report to their offering.

This report provides insights into Rheumatoid Arthritis epidemiology, Rheumatoid Arthritis diagnosed patients, and Rheumatoid Arthritis treatment rate for the top seven pharmaceutical markets. The study measures key indicators such as prevalence of Rheumatoid Arthritis derived from epidemiological analysis, percentage of patients diagnosed with Rheumatoid Arthritis, and percentage of patients treated with Rheumatoid Arthritis therapy.

The study helps executives estimate Rheumatoid Arthritis market potential, assess unmet need, develop drug forecasting models, and build population-based health management frameworks. The information presented in this study is used to evaluate market opportunities, effectively identify target patient population, and align marketing decisions.

The report provides estimates and forecasts of Rheumatoid Arthritis prevalence, Rheumatoid Arthritis diagnosis rate, and Rheumatoid Arthritis treatment rate for the period 2014 - 2020. The information is presented by leading geographies including the US, Germany, France, Spain, Italy, UK, and Japan. The study design is based on collection and interpretation of data from registries, scientific journals and literatures, government databases and other secondary sources.

Key Topics Covered:

1. Rheumatoid Arthritis: Disease Definition

2. Global Rheumatoid Arthritis Patient Flow

3. Rheumatoid Arthritis Patient Flow in the US

4. Rheumatoid Arthritis Patient Flow in Europe

5. Rheumatoid Arthritis Patient Flow in Germany

6. Rheumatoid Arthritis Patient Flow in France

7. Rheumatoid Arthritis Patient Flow in Spain

8. Rheumatoid Arthritis Patient Flow in Italy

9. Rheumatoid Arthritis Patient Flow in UK

10. Rheumatoid Arthritis Patient Flow in Japan

11. Appendix

For more information visit http://www.researchandmarkets.com/research/r42rmg/global_rheumatoid.